Companion Diagnostics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology Type ( Immunohistochemistry, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], In Situ Hybridization, Others ); Indication ( Oncology, Neurology, Others )
Report Code: TIPRE00011772 No. of Pages: 150 Category: Biotechnology Status: Upcoming
MARKET INTRODUCTION
A companion diagnostic is a medical device and provides information that is necessary for the safe and effective use of a corresponding drug or biological product. The diagnostic test helps a health care professional to determine whether a particular therapeutic product is beneficial to patients and can outweigh any potentially severe side effects or risks.
MARKET DYNAMICS
The companion diagnostics market is expected to experience significant growth during the forecast period owing to surge in R&D of targeted therapies, rise in demand for personalized medicine with increase in awareness in emerging economies. Moreover, higher number of unmet needs for the treatment of cancer are majorly driving the growth of the global companion diagnostics market.
MARKET SCOPE
The "Companion Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of companion diagnostics market with detailed market segmentation by technology type and indication. The companion diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in companion diagnostics market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The companion diagnostics market is segmented on the basis of technology type and indication. Based on technology type the market is segmented as immunohistochemistry, polymerase chain reaction [PCR], next generation sequencing [NGS], in situ hybridization, and others. On the basis of indication, the market is categorized as oncology, neurology, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the companion diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The companion diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting companion diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the companion diagnostics market in these regions.
The report covers key developments in the companion diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from companion diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for companion diagnostics in the global market. Below mentioned is the list of few companies engaged in the companion diagnostics market.
The report also includes the profiles of key players in companion diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
A companion diagnostic is a medical device and provides information that is necessary for the safe and effective use of a corresponding drug or biological product. The diagnostic test helps a health care professional to determine whether a particular therapeutic product is beneficial to patients and can outweigh any potentially severe side effects or risks.
MARKET DYNAMICS
The companion diagnostics market is expected to experience significant growth during the forecast period owing to surge in R&D of targeted therapies, rise in demand for personalized medicine with increase in awareness in emerging economies. Moreover, higher number of unmet needs for the treatment of cancer are majorly driving the growth of the global companion diagnostics market.
MARKET SCOPE
The "Companion Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of companion diagnostics market with detailed market segmentation by technology type and indication. The companion diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in companion diagnostics market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The companion diagnostics market is segmented on the basis of technology type and indication. Based on technology type the market is segmented as immunohistochemistry, polymerase chain reaction [PCR], next generation sequencing [NGS], in situ hybridization, and others. On the basis of indication, the market is categorized as oncology, neurology, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the companion diagnostics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The companion diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting companion diagnostics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the companion diagnostics market in these regions.
The report covers key developments in the companion diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from companion diagnostics market are anticipated to have lucrative growth opportunities in the future with the rising demand for companion diagnostics in the global market. Below mentioned is the list of few companies engaged in the companion diagnostics market.
The report also includes the profiles of key players in companion diagnostics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories Molecular, Inc.
- Agilent (Dako Denmark A/S)
- ARUP Laboratories
- BioMerieux SA
- Danaher Corporation (Leica Microsystems)
- Foundation Medicine, Inc.
- Myriad Genetics, Inc.
- Qiagen N.V.
- Roche (Ventana Medical Systems, Inc.)
- Thermo Fisher Scientific (Life Technologies Corporation)
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Companion Diagnostics Market - By Technology Type
1.3.2 Companion Diagnostics Market - By Indication
1.3.3 Companion Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COMPANION DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. COMPANION DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COMPANION DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. COMPANION DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. COMPANION DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. COMPANION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY TYPE
7.1. OVERVIEW
7.2. TECHNOLOGY TYPE MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOHISTOCHEMISTRY
7.3.1. Overview
7.3.2. Immunohistochemistry Market Forecast and Analysis
7.4. POLYMERASE CHAIN REACTION [PCR]
7.4.1. Overview
7.4.2. Polymerase Chain Reaction [PCR] Market Forecast and Analysis
7.5. NEXT GENERATION SEQUENCING [NGS]
7.5.1. Overview
7.5.2. Next Generation Sequencing [NGS] Market Forecast and Analysis
7.6. IN SITU HYBRIDIZATION
7.6.1. Overview
7.6.2. In Situ Hybridization Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. COMPANION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. NEUROLOGY
8.4.1. Overview
8.4.2. Neurology Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. COMPANION DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Companion Diagnostics Market Overview
9.1.2 North America Companion Diagnostics Market Forecasts and Analysis
9.1.3 North America Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.1.4 North America Companion Diagnostics Market Forecasts and Analysis - By Indication
9.1.5 North America Companion Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Companion Diagnostics Market
9.1.5.1.1 United States Companion Diagnostics Market by Technology Type
9.1.5.1.2 United States Companion Diagnostics Market by Indication
9.1.5.2 Canada Companion Diagnostics Market
9.1.5.2.1 Canada Companion Diagnostics Market by Technology Type
9.1.5.2.2 Canada Companion Diagnostics Market by Indication
9.1.5.3 Mexico Companion Diagnostics Market
9.1.5.3.1 Mexico Companion Diagnostics Market by Technology Type
9.1.5.3.2 Mexico Companion Diagnostics Market by Indication
9.2. EUROPE
9.2.1 Europe Companion Diagnostics Market Overview
9.2.2 Europe Companion Diagnostics Market Forecasts and Analysis
9.2.3 Europe Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.2.4 Europe Companion Diagnostics Market Forecasts and Analysis - By Indication
9.2.5 Europe Companion Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Companion Diagnostics Market
9.2.5.1.1 Germany Companion Diagnostics Market by Technology Type
9.2.5.1.2 Germany Companion Diagnostics Market by Indication
9.2.5.2 France Companion Diagnostics Market
9.2.5.2.1 France Companion Diagnostics Market by Technology Type
9.2.5.2.2 France Companion Diagnostics Market by Indication
9.2.5.3 Italy Companion Diagnostics Market
9.2.5.3.1 Italy Companion Diagnostics Market by Technology Type
9.2.5.3.2 Italy Companion Diagnostics Market by Indication
9.2.5.4 Spain Companion Diagnostics Market
9.2.5.4.1 Spain Companion Diagnostics Market by Technology Type
9.2.5.4.2 Spain Companion Diagnostics Market by Indication
9.2.5.5 United Kingdom Companion Diagnostics Market
9.2.5.5.1 United Kingdom Companion Diagnostics Market by Technology Type
9.2.5.5.2 United Kingdom Companion Diagnostics Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Companion Diagnostics Market Overview
9.3.2 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.3.4 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Companion Diagnostics Market
9.3.5.1.1 Australia Companion Diagnostics Market by Technology Type
9.3.5.1.2 Australia Companion Diagnostics Market by Indication
9.3.5.2 China Companion Diagnostics Market
9.3.5.2.1 China Companion Diagnostics Market by Technology Type
9.3.5.2.2 China Companion Diagnostics Market by Indication
9.3.5.3 India Companion Diagnostics Market
9.3.5.3.1 India Companion Diagnostics Market by Technology Type
9.3.5.3.2 India Companion Diagnostics Market by Indication
9.3.5.4 Japan Companion Diagnostics Market
9.3.5.4.1 Japan Companion Diagnostics Market by Technology Type
9.3.5.4.2 Japan Companion Diagnostics Market by Indication
9.3.5.5 South Korea Companion Diagnostics Market
9.3.5.5.1 South Korea Companion Diagnostics Market by Technology Type
9.3.5.5.2 South Korea Companion Diagnostics Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Companion Diagnostics Market Overview
9.4.2 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.4.4 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Companion Diagnostics Market
9.4.5.1.1 South Africa Companion Diagnostics Market by Technology Type
9.4.5.1.2 South Africa Companion Diagnostics Market by Indication
9.4.5.2 Saudi Arabia Companion Diagnostics Market
9.4.5.2.1 Saudi Arabia Companion Diagnostics Market by Technology Type
9.4.5.2.2 Saudi Arabia Companion Diagnostics Market by Indication
9.4.5.3 U.A.E Companion Diagnostics Market
9.4.5.3.1 U.A.E Companion Diagnostics Market by Technology Type
9.4.5.3.2 U.A.E Companion Diagnostics Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Companion Diagnostics Market Overview
9.5.2 South and Central America Companion Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.5.4 South and Central America Companion Diagnostics Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Companion Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Companion Diagnostics Market
9.5.5.1.1 Brazil Companion Diagnostics Market by Technology Type
9.5.5.1.2 Brazil Companion Diagnostics Market by Indication
9.5.5.2 Argentina Companion Diagnostics Market
9.5.5.2.1 Argentina Companion Diagnostics Market by Technology Type
9.5.5.2.2 Argentina Companion Diagnostics Market by Indication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL COMPANION DIAGNOSTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. COMPANION DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES MOLECULAR, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AGILENT (DAKO DENMARK A/S)
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ARUP LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOMERIEUX SA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DANAHER CORPORATION (LEICA MICROSYSTEMS)
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. FOUNDATION MEDICINE, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MYRIAD GENETICS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. QIAGEN N.V.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ROCHE (VENTANA MEDICAL SYSTEMS, INC.)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. THERMO FISHER SCIENTIFIC (LIFE TECHNOLOGIES CORPORATION)
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Companion Diagnostics Market - By Technology Type
1.3.2 Companion Diagnostics Market - By Indication
1.3.3 Companion Diagnostics Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COMPANION DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. COMPANION DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COMPANION DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. COMPANION DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. COMPANION DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. COMPANION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY TYPE
7.1. OVERVIEW
7.2. TECHNOLOGY TYPE MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOHISTOCHEMISTRY
7.3.1. Overview
7.3.2. Immunohistochemistry Market Forecast and Analysis
7.4. POLYMERASE CHAIN REACTION [PCR]
7.4.1. Overview
7.4.2. Polymerase Chain Reaction [PCR] Market Forecast and Analysis
7.5. NEXT GENERATION SEQUENCING [NGS]
7.5.1. Overview
7.5.2. Next Generation Sequencing [NGS] Market Forecast and Analysis
7.6. IN SITU HYBRIDIZATION
7.6.1. Overview
7.6.2. In Situ Hybridization Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. COMPANION DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. Oncology Market Forecast and Analysis
8.4. NEUROLOGY
8.4.1. Overview
8.4.2. Neurology Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. COMPANION DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Companion Diagnostics Market Overview
9.1.2 North America Companion Diagnostics Market Forecasts and Analysis
9.1.3 North America Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.1.4 North America Companion Diagnostics Market Forecasts and Analysis - By Indication
9.1.5 North America Companion Diagnostics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Companion Diagnostics Market
9.1.5.1.1 United States Companion Diagnostics Market by Technology Type
9.1.5.1.2 United States Companion Diagnostics Market by Indication
9.1.5.2 Canada Companion Diagnostics Market
9.1.5.2.1 Canada Companion Diagnostics Market by Technology Type
9.1.5.2.2 Canada Companion Diagnostics Market by Indication
9.1.5.3 Mexico Companion Diagnostics Market
9.1.5.3.1 Mexico Companion Diagnostics Market by Technology Type
9.1.5.3.2 Mexico Companion Diagnostics Market by Indication
9.2. EUROPE
9.2.1 Europe Companion Diagnostics Market Overview
9.2.2 Europe Companion Diagnostics Market Forecasts and Analysis
9.2.3 Europe Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.2.4 Europe Companion Diagnostics Market Forecasts and Analysis - By Indication
9.2.5 Europe Companion Diagnostics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Companion Diagnostics Market
9.2.5.1.1 Germany Companion Diagnostics Market by Technology Type
9.2.5.1.2 Germany Companion Diagnostics Market by Indication
9.2.5.2 France Companion Diagnostics Market
9.2.5.2.1 France Companion Diagnostics Market by Technology Type
9.2.5.2.2 France Companion Diagnostics Market by Indication
9.2.5.3 Italy Companion Diagnostics Market
9.2.5.3.1 Italy Companion Diagnostics Market by Technology Type
9.2.5.3.2 Italy Companion Diagnostics Market by Indication
9.2.5.4 Spain Companion Diagnostics Market
9.2.5.4.1 Spain Companion Diagnostics Market by Technology Type
9.2.5.4.2 Spain Companion Diagnostics Market by Indication
9.2.5.5 United Kingdom Companion Diagnostics Market
9.2.5.5.1 United Kingdom Companion Diagnostics Market by Technology Type
9.2.5.5.2 United Kingdom Companion Diagnostics Market by Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Companion Diagnostics Market Overview
9.3.2 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis
9.3.3 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.3.4 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis - By Indication
9.3.5 Asia-Pacific Companion Diagnostics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Companion Diagnostics Market
9.3.5.1.1 Australia Companion Diagnostics Market by Technology Type
9.3.5.1.2 Australia Companion Diagnostics Market by Indication
9.3.5.2 China Companion Diagnostics Market
9.3.5.2.1 China Companion Diagnostics Market by Technology Type
9.3.5.2.2 China Companion Diagnostics Market by Indication
9.3.5.3 India Companion Diagnostics Market
9.3.5.3.1 India Companion Diagnostics Market by Technology Type
9.3.5.3.2 India Companion Diagnostics Market by Indication
9.3.5.4 Japan Companion Diagnostics Market
9.3.5.4.1 Japan Companion Diagnostics Market by Technology Type
9.3.5.4.2 Japan Companion Diagnostics Market by Indication
9.3.5.5 South Korea Companion Diagnostics Market
9.3.5.5.1 South Korea Companion Diagnostics Market by Technology Type
9.3.5.5.2 South Korea Companion Diagnostics Market by Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Companion Diagnostics Market Overview
9.4.2 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis
9.4.3 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.4.4 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis - By Indication
9.4.5 Middle East and Africa Companion Diagnostics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Companion Diagnostics Market
9.4.5.1.1 South Africa Companion Diagnostics Market by Technology Type
9.4.5.1.2 South Africa Companion Diagnostics Market by Indication
9.4.5.2 Saudi Arabia Companion Diagnostics Market
9.4.5.2.1 Saudi Arabia Companion Diagnostics Market by Technology Type
9.4.5.2.2 Saudi Arabia Companion Diagnostics Market by Indication
9.4.5.3 U.A.E Companion Diagnostics Market
9.4.5.3.1 U.A.E Companion Diagnostics Market by Technology Type
9.4.5.3.2 U.A.E Companion Diagnostics Market by Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Companion Diagnostics Market Overview
9.5.2 South and Central America Companion Diagnostics Market Forecasts and Analysis
9.5.3 South and Central America Companion Diagnostics Market Forecasts and Analysis - By Technology Type
9.5.4 South and Central America Companion Diagnostics Market Forecasts and Analysis - By Indication
9.5.5 South and Central America Companion Diagnostics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Companion Diagnostics Market
9.5.5.1.1 Brazil Companion Diagnostics Market by Technology Type
9.5.5.1.2 Brazil Companion Diagnostics Market by Indication
9.5.5.2 Argentina Companion Diagnostics Market
9.5.5.2.1 Argentina Companion Diagnostics Market by Technology Type
9.5.5.2.2 Argentina Companion Diagnostics Market by Indication
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL COMPANION DIAGNOSTICS MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. COMPANION DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES MOLECULAR, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. AGILENT (DAKO DENMARK A/S)
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ARUP LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOMERIEUX SA
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. DANAHER CORPORATION (LEICA MICROSYSTEMS)
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. FOUNDATION MEDICINE, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MYRIAD GENETICS, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. QIAGEN N.V.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. ROCHE (VENTANA MEDICAL SYSTEMS, INC.)
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. THERMO FISHER SCIENTIFIC (LIFE TECHNOLOGIES CORPORATION)
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott Laboratories Molecular, Inc.
2. Agilent (Dako Denmark A/S)
3. ARUP Laboratories
4. BioMerieux SA
5. Danaher Corporation (Leica Microsystems)
6. Foundation Medicine, Inc.
7. Myriad Genetics, Inc.
8. Qiagen N.V.
9. Roche (Ventana Medical Systems, Inc.)
10. Thermo Fisher Scientific (Life Technologies Corporation)
1. Abbott Laboratories Molecular, Inc.
2. Agilent (Dako Denmark A/S)
3. ARUP Laboratories
4. BioMerieux SA
5. Danaher Corporation (Leica Microsystems)
6. Foundation Medicine, Inc.
7. Myriad Genetics, Inc.
8. Qiagen N.V.
9. Roche (Ventana Medical Systems, Inc.)
10. Thermo Fisher Scientific (Life Technologies Corporation)